Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus

Lupus

Volumn 7, Issue 6, 1998, Pages 420-427

  Elbourne, K B ^a   Keisler, D ^b   McMurray, R W ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Hormone; Lupus; Mice; Prolactin

Indexed keywords

DNA ANTIBODY; ESTROGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNITY; ESTROGENS; FEMALE; LONGEVITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PROLACTIN;

EID: 0031679839     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920352     Document Type: Conference Paper

References (50)

1. Rothfield N. Clinical features of systemic lupus erythematosus. In: Kelley WN, Harris ED,. Ruddy S, Sledge CB (eds.) Textbook of Rheumatology WB Suanders Co.: Philadelphia, 1985; 1069-1089.
2. Reeves WH, Lahita RB. Clinical presentation of systemic lupus erythematosus in the adult. In: Lahita RG (ed). Systemic Lupus Erythematosus Churchill Livingston: New York. 1992; 369-396.
3. Inman RD. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 849-852.
4. Theofilopoulos AN. Sex and Sex Hormones. In: Lahita RG (ed). Systemic Lupus Erythematosus Churchill Livingston: New York. 1992; 167-169
5. Masi AT, Kaslow RA. Sex effects in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 480-483
6. Rose E, Pillsbury DM. Lupus erythematosus (erythematodes) and ovarian function: Observations on a possible relationship with a report of six cases. Ann Intern Med 1944; 21: 1022-1034.
7. Jungers P et al. Influence of oral contraceptive therapy on activity of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 618-623.
8. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538-1545.
9. Parke AL. Pregnancy and SLE. In: Lahita RG (ed). Systemic Lupus Erythematosus Churchill Livingston: New York, 1992; 543-560.
10. Lahita RB et al. Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981; 53: 174-178.
11. Lahita RG, Kunkel HG, Barlow HL Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 1517-1521.
12. Lahita RG et al Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1979; 20: 1195-1198.
13. McMurray RW et al. Lonstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease. J Rheum 194; 21: 843-850.
14. Jara LJ et al. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992; 303: 222-226.
15. Theofilopoulos AN. Murine models of lupus. Lahita RG (ed). Systemic Lupus Erythematosus 2nd edition, Churchill Livingston: New York, 1992; 121-194.
16. Roubinian J, Talal N, Suteri PK, Sadakian JA. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 1979; 22: 1162-1169.
17. Steinberg AD et al. Approach to the study of the role of sex hormones in autoimmuinty. Arthritis Rheum 1979; 22: 1170-1176.
18. McMurrary R et al. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991; 147: 2780-3787.
19. Frantz AG. Prolactin. N Eng J Med 1978; 298: 201-207.
20. Reichlin S. Neuroendocrinology. In: Wilson JD, Foster DW (eds). Williams' Textbook of Endocrinology WB Saunders: Philadelphia, 1992; 203: 173-175.
21. Chen CL, Meites J. Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats Endocrinol 1970; 86: 503-508
22. Nogami H. Fine structural heterogeneity and morphologic changes in rat pituitary prolactin cells after estrogen and testosterone treatment. Cell Tissue Res 1984; 237: 195-199
23. Carr BR. Disorders of the ovary and female reproductive tract. In: Wilson JD, Foster DW (eds). Williams' Textbook of Endocrinology. WB Saunders. Philadelphia, 1992; 733-798.
24. Carlsten H, Tarowski A, Homdahl R, Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL/lpr/lpr mice Clin Exp Immunol 1990; 80: 467-473.
25. Holmdahl R, Carlsten H, Jansson L, Larsson P Oestrogen is a potent immunomodulator murine experimental rheumatoid disease. Brit J Rheumatol 1989, 28 (Suppl I): 54-58.
26. Carlsten H, Holmdahl R, Tarkowski A, Nilsson LA. Oestradiol suppression of delayed type hypersensitivity in autoimmune (NZB/NZW) F1 mice is a trait inherited from the healthy NZW parental strain. Immunol 1989; 67: 205-209.
27. Carlsten H, Nilsson N, Jonsson R, Tarkowski A. Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell mediated lesions. J Autoimmunity 1991; 4. 845-856.
28. Adler RA The anterior pituitary-grafted rat: A valid model of chronic hyperprolactinemia. Endocr Rev 1986; 7: 320-313.
29. Mann MA, Michael SD, Svare B Ergot drugs suppress plasma levels of prolactin (PRL) but not growth hormone (GH), luteinizing hormone (LH) or corticosterone (CORT) in parturient mice. Pharmacol Biochem Behavior 1982; 17: 837-840.
30. Zhou T et al. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse. J Immunol 1993; 150: 3651-3659.
31. Abbas AK, Uarioste S, Collins TL, Bloom WH Heterogeneity of helper/inducer T lymphocytes IV. Stimulation of resting and activated B cells by Th1 and Th2 clones. J Immunol 1990; 144: 2031-2037.
32. Chi HJ, Shin SH. The effect of exposure to ether on prolactin secretion and the half-life of endogenous prolactin in normal and castrated male rats. Neuroendocrinology 1978; 26: 193-201
33. Fox HS, Bond BL, Parslo TG. Estrogen regulates the IFN-gamma promoter. J Immunol 1991; 146: 4362-4357.
34. Sthoeger ZM, Chiorazzi N, Lahita RG Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen induced human B-cell differentiation. J Immunol 1998; 141: 91-98.
35. Ahmed SA, Dauphinee MH, Talal N. Effect of short-term administration of sex hormones on normal and autoimmune mice. J Immunol 1984; 134: 204-210.
36. Smithson G, Medicne K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 1995; 155: 3409-3417.
37. Schwarz LA, Stevens AM, Hrachovy JA. Yu-Lee L. Interferon regulatory factor-I is inducible by prolactin, interleukin-2, and concanavalin A in T cells. Mol Cell Endocrinol 1992; 86: 103-110.
38. Yu-Lee LY, Stevens AM, Hrachovy JA, Schwartz LA. Prolactin-mediated regulation of gene transcription in lymphocytes. Ann NY Acad Sci 1990; 594: 146-155.
39. Cross RJ, Campbell JL, Roszman TL. Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland. J Neuroimmunol 1989; 25: 29-35.
40. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L Progesterone favors the development of human T helper cells producing Th2-Type cytokines and promotes both IL-4 production and membrane CD30 expression in established Thl cell clones. J Immunol 1995; 155: 128-133
41. Walker SE, McMurray RW, Besch-Williford CL, Keisler D. Premature death with bladder outlet obstruction and hyperprolactinemia in the New Zealand Black × New Zealand White mice treated with ethinyl estradiol and 17 beta-estradiol. Arthritis Rheum 1992, 35: 1387-1392.
42. Morikawa K, Oseko F, Moreikawa S. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol 1994, 95: 514-518.
43. Morikawa K, Oseko F, Morikawa S. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin Exp Immuno 1993; 93: 200-205.
44. Power RF, Lydon JP, Conneely BW, O'Malley BW Dopamine activation of an orphan steroid receptor superfamily. Science 1991; 252: 1546-1548.
45. E Nagy et al. Immunomodulation by bromocriptine. Immunopharmacology 1983, 6: 231-243.
46. Bernton EW, Metzler MS, Holaday JW. Suppression of macrophage activation and T lymphocyte function in hypoprolactinemic mice. Science 1988; 239: 401-404.
47. Thorner MO, Vance ML, Horvath E, Kovacs K. The Anterior Pituitary. In: Wilson JD, Foster DW (eds). Williams ' Textbook of Endocrinology. WB Saunders: Philadelphia, 1992; 226-228.
48. Jacobsen JD, Nisula BC, Steinberg AD. Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs Endocrinol 1994; 134: 2516-2523.
49. Cleavenger CV, Russell DH, Appasamy PM, Prystowsky MB. Regulation of interteukin-2 driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 1990; 87: 6460-6464.
50. McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatology 1995; 23: 1576-1590.